Patent details
EP4017494 Title: THE VMAT2 INHIBITOR VALBENAZINE FOR USE IN A METHOD OF TREATING A NEUROLOGICAL OR PSYCHIATRIC DISORDER IN PATIENTS WITH SEVERE RENAL IMPAIRMENT
Basic Information
- Publication number:
- EP4017494
- PCT Application Number:
- US2020047392
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP207649104
- PCT Publication Number:
- WO2021041208
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- THE VMAT2 INHIBITOR VALBENAZINE FOR USE IN A METHOD OF TREATING A NEUROLOGICAL OR PSYCHIATRIC DISORDER IN PATIENTS WITH SEVERE RENAL IMPAIRMENT
- French Title of Invention:
- L'INHIBITEUR DE VMAT2 VALBENAZINE POUR SON UTILISATION DANS UNE MÉTHODE DE TRAITEMENT D'UN TROUBLE NEUROLOGIQUE OU PSYCHIATRIQUE CHEZ DES PATIENTS PRÉSENTANT UNE INSUFFISANCE RÉNALE GRAVE
- German Title of Invention:
- VMAT2-HEMMER VALBENAZIN ZUR VERWENDUNG IN EINEM VERFAHREN ZUR BEHANDLUNG EINER NEUROLOGISCHEN ODER PSYCHIATRISCHEN STÖRUNG BEI PATIENTEN MIT STARKER NIERENSCHÄDIGUNG
- SPC Number:
Dates
- Filing date:
- 21/08/2020
- Grant date:
- 20/08/2025
- EP Publication Date:
- 29/06/2022
- PCT Publication Date:
- 04/03/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 20/08/2025
- EP B1 Publication Date:
- 20/08/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 21/08/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/08/2025
- Name:
- Neurocrine Biosciences, Inc.
- Address:
- 6027 Edgewood Bend Court, San Diego, CA 92130, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 27/08/2025
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- LUO, Sha Rosa
- Address:
- United States (US)
2
- Name:
- LOEWEN, Gordon Raphael
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201962890697 P
- Priority Date:
- 23/08/2019
- Priority Country:
- United States (US)
2
- Priority Number:
- 202063028754 P
- Priority Date:
- 22/05/2020
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/4738; A61P 13/12; A61P 25/00; A61P 25/14; A61P 25/16; A61P 25/24; A61P 25/28; A61K 9/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202534
- Publication date:
- 20/08/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202537
- Publication date:
- 10/09/2025
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 31/08/2026
- Annual Fee Number:
- 7
- Annual Fee Amount:
- 82 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 24/09/2025
- Last Annual Fee Paid Number:
- 6
- Last Annual Fee Paid Amount:
- 66 Euro
- Payer:
- MEWBURN & ELLIS LLP
| Filing date | Document type | Number of pages |
|---|---|---|
| 25/08/2025 | Power Of Attorney | 1 |
| 27/08/2025 | Outgoing Correspondence | 1 |